Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. J Cardiac Fail. 2015;21:519-534.Fang JC, Ewald GA, Allen LA, Butler J, Westlake Canary CA, Colvin-Adams M, et al. Advanced (stage D) heart failure: a statement from the ...
Clinical definition and epidemiology of advanced heart failure. Am Heart J.1998;135:S204-S215.Google Scholar 6. Hunt SA, Baker DW, Chin MH, Cinquegrani MP. et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. J Am Coll Cardiol.2001;38:...
We present a unique pathway that incorporates guidelines, recent data, and expert opinion to help general cardiologists determine which patients should be referred for transplantation or durable mechanical circulatory support, and when they should be referred. Decision making on referral to the heart ...
E Brown,W Whiteley,P Kale - 《Journal of Heart & Lung Transplantation》 被引量: 0发表: 2023年 Palliative care in heart failure guidelines: A comparison of the 2021 ESC and the 2022 AHA/ACC/HFSA guidelines on heart failure The role of palliative care for patients with heart failure (HF)...
Masoudi FA, McKelvie R, Parent MC, Poon S, Rajda M, Sharma A, Siatecki K, Storm K, Sussex B, Van Spall H, Yip AMC. CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction. Can J Cardiol. 2021;37:531–...
HF, heart failure; LVAD, left ventricular assist device. Full size image Figure 2 Numbers of HF patients referred to our advanced HF center from HBHs and LBHs. HF, heart failure; LBHs, low bed volume hospitals; HBHs, high bed volume hospitals. Full size image Differences in patient ...
Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ...
Intermittent ambulatory levosimendan administration has been shown in several small randomized controlled trials to benefit patients with advanced heart failure, preventing heart failure rehospitalization and mortality. We aim to investigate the totality of high-quality evidence regarding the efficacy and safet...
Heart failure is a progressive disease that significantly impacts patient quality of life. Patients with heart failure value quality of life highly, often prioritizing it over survival. Durable mechanical circulatory support (MCS) represents an opportunity to improve health-related quality of life (HRQOL...
Methods and results In this multicentre, prospective, randomized, controlled trial, patients with stable heart failure and LVAD were randomly assigned (2:1) to 12?weeks of supervised exercise training or usual care, with 12?weeks of follow‐up. The primary endpoint was the change in peakVO2 ...